Trials / Conditions / Neuralgia, Postherpetic

Neuralgia, Postherpetic

28 registered clinical trials studyying Neuralgia, Postherpetic — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Subcutaneous Lidocaine Injection in Acute Herpes Zoster Neuralgia and Post-herpetic Neuralgia NCT06882525	Ankara City Hospital Bilkent	N/A
Recruiting	High-Voltage Long-Duration Pulsed Radiofrequency Combined With Liposomal Bupivacaine Subcutaneous Block for He NCT06959147	Shirong Tan	Phase 4
Unknown	The Effect of Epidural Steroid Use in Patients With Continous Epidural Block in PHN Patients. NCT03995563	Korea University Guro Hospital	Phase 4
Completed	Pulsed Electromagnetic Field Therapy Versus Transcutaneous Electrical Nerve Stimulation in on Post-herpetic Ne NCT04488835	Cairo University	N/A
Completed	Evaluation of an Effectiveness and Safety of the Electroacupuncture in the Management of Intractable Neuropath NCT03315598	Seoul National University	N/A
Completed	Mannitol Cream for Post Herpetic Neuralgia NCT02484170	University of British Columbia	Phase 1 / Phase 2
Withdrawn	Dose Ranging Trial to Determine the Safety and Efficacy of EMA401 in Patients With PHN NCT02426411	Spinifex Pharmaceuticals Pty Ltd	Phase 2
Terminated	A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia NCT01678924	Allergan	Phase 2
Completed	Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve D NCT01252160	Astellas Pharma Inc	Phase 4
Unknown	Effect of Opioids in Neuropathic Pain in Postherpetic Patients NCT01102101	Medical University of Vienna	Phase 3
Completed	A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia NCT01129531	Allergan	Phase 2
Terminated	A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Neuropathic Pain ( NCT00964990	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 2
Completed	PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia NCT00614705	Pfizer	Phase 2
Completed	Safety and Efficacy of Gabapentin in Postherpetic Neuralgia NCT00636636	Depomed	Phase 3
Completed	A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin NCT00617461	XenoPort, Inc.	Phase 2
Completed	A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN) NCT00619476	XenoPort, Inc.	Phase 2
Completed	RN624 For Pain Of Post-Herpetic Neuralgia NCT00568321	Pfizer	Phase 2
Completed	Neuropathic Pain Syndrome Patient Study (MK-0000-072) NCT00570310	Merck Sharp & Dohme LLC	Phase 1
Completed	A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia NCT00424372	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 3
Completed	Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic Neuralgia NCT00377598	Takeda	Phase 2 / Phase 3
Completed	A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neur NCT00394901	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 3
Completed	Safety and Efficacy of Gabapentin in Postherpetic Neuralgia NCT00335933	Depomed	Phase 3
Terminated	A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgi NCT00282763	Merck Sharp & Dohme LLC	Phase 2
Terminated	Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004) NCT00245544	Merck Sharp & Dohme LLC	Phase 2
Terminated	Lamictal in the Treatment of Post-Herpetic Neuralgia NCT00295776	George Washington University	Phase 2 / Phase 3
Completed	A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neur NCT00160667	UCB Pharma	Phase 2
Completed	A Study Of The Efficacy Of Gabapentin In Neuropathic Pain Patients As Measured By Quantitative Sensory Testing NCT00674687	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	N/A
Completed	A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN) NCT00160511	UCB Pharma	Phase 2